CD226 (NM_006566) Human Tagged ORF Clone Lentiviral Particle
CAT#: RC210437L1V
- LentiORF®
Lenti ORF particles, CD226 (Myc-DDK tagged) - Human CD226 molecule (CD226), 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 8,930.00
货期*
详询
规格
Cited in 1 publication. |
Product images
经常一起买 (3)
Specifications
Product Data | |
Product Name | CD226 (NM_006566) Human Tagged ORF Clone Lentiviral Particle |
Synonyms | DNAM-1; DNAM1; PTA1; TLiSA1 |
Vector | pLenti-C-Myc-DDK |
ACCN | NM_006566 |
ORF Size | 1008 bp |
Sequence Data |
The ORF insert of this clone is exactly the same as(RC210437).
|
OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
Reference Data | |
RefSeq | NM_006566.1, NP_006557.1 |
RefSeq Size | 2664 bp |
RefSeq ORF | 1011 bp |
Locus ID | 10666 |
Protein Families | Druggable Genome, Transmembrane |
Protein Pathways | Cell adhesion molecules (CAMs) |
MW | 38.6 kDa |
Gene Summary | This gene encodes a glycoprotein expressed on the surface of NK cells, platelets, monocytes and a subset of T cells. It is a member of the Ig-superfamily containing 2 Ig-like domains of the V-set. The protein mediates cellular adhesion of platelets and megakaryocytic cells to vascular endothelial cells. The protein also plays a role in megakaryocytic cell maturation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2015] |
Citations (1)
The use of this cDNA Clones has been cited in the following citations: |
---|
Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8+ T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy.
,null,
Immunity
,PubMed ID 33053331
[CD226]
|
Documents
Product Manuals |
FAQs |
SDS |
Resources
You may also need
Customer
Reviews
Loading...